The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
The use of intravenous morphine for breakthrough pain in terminal cancer patients admitted to hospice center.
Ik-Joo Chung
No relevant relationships to disclose
Sang-Hee Cho
No relevant relationships to disclose
Jun-Eul Hwang
No relevant relationships to disclose
Jae-Sook Ahn
No relevant relationships to disclose
Won-young Choi
No relevant relationships to disclose
Hyun-Jeong Shim
No relevant relationships to disclose